Showing 430 – 440 of 1307 results
-
Novel Coronavirus and the Economy
In this week’s Economics Weekly, we examine the current novel coronavirus outbreak and its possible implications for economic growth.
-
Fattmerchant and Greater Sum Ventures
William Blair acted as exclusive financial advisor to Fattmerchant in connection with its recapitalization by Greater Sum Ventures.
-
Form CRS Relationship Summary
View our client relationship summary.
-
Trupanion Inc Initiation
William Blair initiated research coverage of Trupanion, Inc. (TRUP $35.31), a leader in the global pet insurance market.
-
Eargo Inc Initiation
William Blair & Company initiated research coverage of Eargo, Inc. (EAR $34.75). A direct-to-consumer telehealth company, Eargo offers a hearing aid solution within the potential $30 billion domestic total addressable market.
-
Twist Bioscience Corporation and Zymergen Inc Initiation
William Blair initiated research coverage of Twist Bioscience Corporation (TWST $122.56) and Zymergen Inc. (ZY $41.15), two companies in the burgeoning synthetic biology ecosystem.
-
Open Lending Corporation Initiation
William Blair & Company initiated research coverage of Open Lending Corporation (LPRO $40.17). Open Lending is a leading provider of cloud-based lending enablement and risk-analytics software to automotive lenders, including regional banks, credit unions, and OEM captives.
-
Nicole Macias
View biography for Nicole Macias, Manager I, Business Management.
-
Sebastien Naji
View biography for Sebastien Naji, Research Analyst.
-
Brandon Vazquez
View biography for Brandon Vazquez, Research Analyst.